<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PMQ3SLQF</identifier><date>2015</date><creator>Štuhec, Matej</creator><relation>documents/doc/P/URN_NBN_SI_doc-PMQ3SLQF_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PMQ3SLQF_001.txt</relation><format format_type="issue">1/2</format><format format_type="volume">5</format><format format_type="type">article</format><format format_type="extent">str. 6-9</format><identifier identifier_type="COBISSID">14008883</identifier><identifier identifier_type="ISSN">2232-416X</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PMQ3SLQF</identifier><language>eng</language><publisher publisher_location="Murska Sobota">PAZU</publisher><source>Anali PAZU</source><rights>BY-NC-ND</rights><subject language_type_id="eng">adverse event</subject><subject language_type_id="slv">Alzheimerjeva bolezen</subject><subject language_type_id="eng">Alzheimer's disease</subject><subject language_type_id="eng">clinical pharmacy</subject><subject language_type_id="slv">klinična farmacija</subject><subject language_type_id="slv">neželeni dogodki</subject><subject language_type_id="eng">parkinsonism</subject><subject language_type_id="slv">parkinsonizem</subject><title>a case study and the review of the literature</title><title>Memantine associated with parkinsonism in a patient with Alzheimer's disease</title><title>Parkinsonizem povzročen z memantinom pri bolniku z Alzheimerjevo boleznijo</title><title>študija primera in pregled literature</title></Record>